Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to predict which lymphedema patients benefit from surgery

NCT ID NCT07614815

Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test whether special imaging scans (ICG lymphography and high-frequency ultrasound) can predict how well a surgery called lymphaticovenous anastomosis works for arm swelling after breast cancer treatment. Thirty women with mild to moderate lymphedema will be scanned before surgery, and their outcomes will be tracked. The goal is to find imaging clues that point to a successful recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
lymphaticovenous anastomosis (surgery)
What this could lead to
If successful, this could help doctors better predict which patients will benefit from lymphaticovenous anastomosis surgery for arm swelling after breast cancer.
What could go wrong
This is a small, early-stage study with only 30 participants. The imaging methods may not reliably predict surgical outcomes, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jun 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Female patients aged 18 to 75 years. * Unilateral secondary upper limb lymphedema following mastectomy with axillary lymph node dissection. * Minimum interval of six months from completion of oncological treatment (surgery, radiotherapy, systemic therapy) to enrollment. * ISL clinical stage I or II at the time of enrollment; late stage II eligible if patent lymphatic vessels are identified on preoperative HFUS. * Provision of written informed consent (prospective phase). Exclusion Criteria: * Bilateral upper limb lymphedema. * Active locoregional or distant oncological recurrence. * Prior lymphatic surgery on the affected limb. * Severe peripheral vascular disease. * Pregnancy or planned pregnancy during the study follow-up period. * Documented hypersensitivity to indocyanine green or iodine

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer lymphedema are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Cancer Lymphedema lymphedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer lymphedema Lymphedema arm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Assiut University Hospital

    Asyut, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.